ILLUMINA, INC. ILMN
Last close
218.22
2026-09-04
Market cap
$32.95B
2026-06-28 share count
52-week range
88.00 - 231.81
Valuation FY2025 figures against the last close
P/S7.6x
P/E40.0x
P/FCF35.4x
EV/EBITDA30.6x
Dividend yield—
Diluted EPS5.45
Annual financial statements
Income statement
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $4.34B | $4.37B | $4.50B | $4.58B | $4.53B | $3.24B | $3.54B | $3.33B | $2.75B | $2.40B |
| Cost of revenue | $1.47B | $1.51B | $1.76B | $1.61B | $1.37B | $1.04B | $1.08B | $1.03B | $926.0M | $732.0M |
| Gross profit | $2.87B | $2.86B | $2.74B | $2.97B | $3.15B | $2.20B | $2.47B | $2.30B | $1.83B | $1.67B |
| R&D | $967.0M | $1.17B | $1.35B | $1.32B | $1.19B | $682.0M | $647.0M | $623.0M | $546.0M | $504.0M |
| SG&A | $1.09B | $1.09B | $1.61B | $1.30B | $2.09B | $941.0M | $835.0M | $794.0M | $674.0M | $584.0M |
| Total operating expenses | $2.06B | $3.69B | $3.81B | $7.15B | $3.28B | $1.62B | $1.48B | $1.42B | $1.22B | $1.08B |
| Operating income | $807.0M | -$833.0M | -$1.07B | -$4.18B | -$123.0M | $580.0M | $985.0M | $883.0M | $606.0M | $587.0M |
| Interest expense | $101.0M | $100.0M | $77.0M | $26.0M | $61.0M | $49.0M | $52.0M | $57.0M | $37.0M | $33.0M |
| Pre-tax income | $1.09B | -$1.18B | -$1.12B | -$4.34B | $884.0M | $856.0M | $1.12B | $894.0M | $1.04B | $561.0M |
| Income tax | $236.0M | $44.0M | $44.0M | $68.0M | $122.0M | $200.0M | $128.0M | $112.0M | $365.0M | $133.0M |
| Net income | $850.0M | -$1.22B | -$1.16B | -$4.40B | $762.0M | $656.0M | $1.00B | $826.0M | $726.0M | $463.0M |
| EPS, basic | 5.47 | -7.69 | -7.34 | -28.00 | 5.07 | 4.48 | 6.81 | 5.63 | 4.96 | 3.09 |
| EPS, diluted | 5.45 | -7.69 | -7.34 | -28.00 | 5.04 | 4.45 | 6.74 | 5.56 | 4.92 | 3.07 |
| Shares, diluted (wtd. avg.) | $156.0M | $159.0M | $158.0M | $157.0M | $151.0M | $148.0M | $149.0M | $149.0M | $148.0M | $148.0M |
Balance sheet
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | $1.42B | $1.13B | $1.05B | $2.01B | $1.23B | $1.81B | $2.04B | $1.14B | $1.23B | $735.0M |
| Short-term investments | $215.0M | $93.0M | $6.0M | $26.0M | $107.0M | $1.66B | $1.37B | $2.37B | $920.0M | $824.0M |
| Receivables | $854.0M | $735.0M | $734.0M | $671.0M | $648.0M | $487.0M | $573.0M | $514.0M | $411.0M | $381.0M |
| Inventory | $564.0M | $547.0M | $587.0M | $568.0M | $431.0M | $372.0M | $359.0M | $386.0M | $333.0M | $300.0M |
| Total current assets | $3.29B | $2.75B | $2.61B | $3.56B | $2.71B | $4.48B | $4.45B | $4.49B | $2.98B | $2.32B |
| Property, plant and equipment | $759.0M | $815.0M | $1.01B | $1.09B | $1.02B | $922.0M | $889.0M | $1.07B | $931.0M | $713.0M |
| Goodwill | $1.11B | $1.11B | $2.54B | $3.24B | $7.11B | $897.0M | $897.0M | $831.0M | $771.0M | $776.0M |
| Other intangibles | $210.0M | $295.0M | $2.99B | $3.29B | $3.25B | $142.0M | $145.0M | $185.0M | $175.0M | $243.0M |
| Total assets | $6.64B | $6.30B | $10.11B | $12.25B | $15.22B | $7.58B | $7.32B | $6.96B | $5.26B | $4.28B |
| Accounts payable | $240.0M | $221.0M | $245.0M | $293.0M | $332.0M | $192.0M | $149.0M | $184.0M | $160.0M | $138.0M |
| Short-term debt | — | — | — | — | — | $511.0M | $0 | $1.11B | $10.0M | $2.0M |
| Total current liabilities | $1.58B | $1.55B | $1.57B | $2.77B | $1.09B | $1.24B | $665.0M | $1.80B | $746.0M | $705.0M |
| Long-term debt | — | — | — | — | — | $673.0M | $1.14B | $890.0M | $1.18B | $1.06B |
| Retained earnings | -$392.0M | -$1.24B | -$19.0M | $1.14B | $5.49B | $4.72B | $4.07B | $3.08B | $2.26B | $1.49B |
| Total equity | $2.72B | $2.37B | $5.75B | $6.60B | $10.74B | $4.69B | $4.61B | $3.85B | $2.75B | $2.27B |
Cash flow
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $1.08B | $837.0M | $478.0M | $392.0M | $545.0M | $1.08B | $1.05B | $1.14B | $875.0M | $779.0M |
| Depreciation and amortisation | $270.0M | $354.0M | $432.0M | $394.0M | $251.0M | $187.0M | $188.0M | $179.0M | $156.0M | $141.0M |
| Stock-based compensation | $275.0M | $370.0M | $380.0M | $366.0M | $754.0M | $194.0M | $194.0M | $193.0M | $164.0M | $129.0M |
| Capital expenditure | $148.0M | $128.0M | $195.0M | $286.0M | $208.0M | $189.0M | $209.0M | $296.0M | $310.0M | $260.0M |
| Investing cash flow | -$55.0M | -$178.0M | -$231.0M | -$591.0M | -$1.07B | -$554.0M | $745.0M | -$1.81B | -$214.0M | -$515.0M |
| Financing cash flow | -$744.0M | -$570.0M | -$1.21B | $1.00B | -$51.0M | -$766.0M | -$897.0M | $594.0M | -$176.0M | -$296.0M |
| Buybacks | $742.0M | $116.0M | $0 | $0 | $0 | $736.0M | $324.0M | $201.0M | $251.0M | $249.0M |
Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001193125-26-149669.
Others in SIC 3826
| Ticker | Company | Market cap | P/E | Revenue growth |
|---|---|---|---|---|
| A | AGILENT TECHNOLOGIES, INC. | $42.53B | 33.0x | 6.7% |
| WAT | WATERS CORP /DE/ | $40.22B | 38.0x | 7.0% |
| MTD | METTLER TOLEDO INTERNATIONAL INC/ | $26.95B | 32.0x | 4.0% |
| RVTY | REVVITY, INC. | $14.53B | 62.9x | 3.7% |
| BIO | BIO-RAD LABORATORIES, INC. | $10.33B | 13.9x | 0.7% |
| AVTR | Avantor, Inc. | $10.22B | — | -3.4% |
| BRKR | BRUKER CORP | $8.88B | — | 2.1% |
| TXG | 10x Genomics, Inc. | $8.14B | — | 5.2% |